Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05670847
PHASE2/PHASE3

Exogenous Ketone Esters for Drug Resistant Epilepsy

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

This study aims to investigate the efficacy of add-on exogenous ketone esters for treating children with drug-resistant epilepsy

Official title: Efficacy of Ketone Esters for Children With Drug Resistant Epilepsy

Key Details

Gender

All

Age Range

1 Year - 16 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2023-01-10

Completion Date

2025-07-01

Last Updated

2024-11-27

Healthy Volunteers

No

Interventions

DRUG

Exogenous ketone ester

500 mg/kg orally three times daily (with at least 4 hours between each dose) for 28 days

Locations (1)

Department of Pediatrics at Sohag University Hospital

Sohag, Egypt